Type Whole antibody Target FR-alpha CAS Number 896723-44-7 | Source Humanized ATC code none ChemSpider none | |
 | ||
How to pronounce farletuzumab
Farletuzumab (MORAb-003) is a monoclonal antibody which is being investigated for the treatment of ovarian cancer.
Contents
This drug was developed by Morphotek, Inc.
It is targeted at FR-alpha which is overexpressed in some cancers such as ovarian cancer.
How to pronounce farletuzumab
References
Farletuzumab Wikipedia(Text) CC BY-SA